Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with invasive breast cancer confirmed by a tissue sample (biopsy)
- People who have had breast-conserving surgery (where only the tumour and some surrounding tissue are removed, not the whole breast)
- People whose tumour measured no more than 5 cm, and who had no more than 2 sentinel lymph nodes (the first nodes cancer might spread to) that tested positive for cancer
- People whose surgical margins were clear, meaning no cancer cells were found at the edges of the removed tissue
- People who are in reasonably good general health (confirm with trial site for specific health score details)
- People aged 18 or older
- People who are willing to provide written consent to participate
Who may not be able to join:
- People who have previously had radiation therapy to the chest area
- People who have certain connective tissue disorders (conditions affecting joints, skin, and other tissues)
- People whose cancer has spread to other parts of the body (distant metastases)
- People with serious lung or heart conditions
- People who received chemotherapy or other systemic treatments before their surgery (neoadjuvant therapy)
- People who had a full axillary lymph node dissection (removal of many lymph nodes from the armpit)
- People who did not have any surgical investigation of the lymph nodes in the armpit
- People who had a full mastectomy (complete removal of the breast)
- People whose sentinel lymph nodes contained only very tiny amounts of cancer cells (micrometastasis or isolated tumour cells)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Maria Cristina Leonardi, MD, European Institute of Oncology
Phone: +39 02 94372156
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of patients with arm lymphedema
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.